参考文献/References:
[1]Fukuda T,Naganuma M,Sugimoto S,et al. The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy:a report from the IBD registry[J]. PLoS One,2017,12(11):e0187737.
[2]Spagnuolo R,Dattilo V,D’Antona L,et al. Deregulation of SGK1 in ulcerative colitis:a paradoxical relationship between immune cells and colonic epithelial cells[J]. Inflamm Bowel Dis,2018,24(9):1967-1977.
[3]郑慧怡,马芙蓉,罗晓清,等. 牛初乳通过调节肠道菌群对小鼠溃疡性结肠炎的改善作用[J]. 中南医学科学杂志,2020,48(5):531-535.
[4]Song EM,Lee HS,Park SH,et al. Clinical characteristics and long-term prognosis of elderly onset ulcerative colitis[J]. J Gastroenterol Hepatol,2018,33(1):172-179.
[5]Al-Talabany S,Mordi I,Graeme Houston J,et al. Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes[J]. BMC Cardiovasc Disord,2018,18(1):31.
[6]Barnes EL,Beery RM,Schulman AR,et al. Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database[J]. Inflamm Bowel Dis,2016,22(9):2229-2237.
[7]Rahier JF,Magro F,Abreu C,et al. Second European evidence-based consensus on the prevention,diagnosis and management of opportunistic infections in inflammatory bowel disease[J]. J Crohns Colitis,2014,8(6):443-468.
[8]Garg M,Hendy P,Ding JN,et al. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis[J]. J Crohns Colitis,2018,12(8):963-972.
[9]Yan Y,Sun J,Xie X,et al. Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis[J]. RSC Advances,2018,8(5):2561-2574.
[10]Bermejo F,Aguas M,Chaparro M,et al. Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis(GETECCU) on the use of thiopurines in inflammatory bowel disease[J]. Gastroenterol Hepatol,2018,41(3):205-221.
[11]Butler T,Kerley CP,Altieri N,et al. Optimum nutritional strategies for cardiovascular disease prevention and rehabilitation(BACPR)[J]. Heart,2020,106(10):724-731.
[12]Flora GD,Nayak MK. A brief review of cardiovascular diseases,associated risk factors and current treatment regimes[J]. Curr Pharm Des,2019,25(38):4063-4084.
[13]Triches CB,Mayer S,Quinto BMR,et al. Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension[J]. J Clin Hypertens(Greenwich),2018,20(5):935-941.
[14]Liu W,Wang T,Sun P,et al. Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD[J]. Exp Ther Med,2019,17(3):1756-1760.
[15]Shentova R,Yaneva P,Baycheva M,et al. Role of laboratory markers in paediatric inflammatory bowel disease[J]. J Crohns Colitis,2018,12(1):S456-S463.
[16]Canseco-Avila LM,Lopez-Roblero A,Serrano-Guzman E,et al. Polymorphisms -455G/A and -148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events[J]. Dis Markers,2019,2019:5769514.
[17]Jang JY,Bae JS,Kang MG,et al. The impact of serial measurement of plasma fibrinogen and cardiovascular outcomes after percutaneous coronary intervention in patients with coronary artery disease[J]. Eur Heart J,2018,39(1):168-172
[18]Zhang C,Jia Y,Jia Y,et al. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer[J]. Int J Clin Oncol,2018,23(6):1070-1075.
[19]Chen M,Li Z,Zhang Z,et al. Intervention of integrative medicine treatment has impact on serum levels of ET-1,TNF-α,MLT in RA-CVD[J]. Saudi J Biol Sci,2018,25(5):959-964.
[20]Liu B,Xu L,Yu X,et al. Protective effect of KLF15 on vascular endothelial dysfunction induced by TNF-α[J]. Mol Med Rep,2018,18(2):1987-1994.
[21]Alánová P,Chytilová A,Necká? J,et al. Myocardial ischemic tolerance in rats subjected to endurance exercise training during adaptation to chronic hypoxia[J]. J Appl Physiol (1985),2017,122(6):1452-1461.
[22]Moretti R,Caruso P. The controversial role of homocysteine in neurology:from labs to clinical practice[J]. Int J Mol Sci,2019,20(1):231-251.
[23]Wang XJ,Tian DC,Wang FW,et al. Astaxanthin inhibits homocysteine-induced endothelial cell dysfunction via the regulation of the reactive oxygen species-dependent VEGF-VEGFR2-FAK signaling pathway[J]. Mol Med Rep,2019,19(6):4753-4760.
[24]Raffield LM,Ellis J,Olson NC,et al. Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study,the Multi-Ethnic Study of Atherosclerosis,and the Coronary Artery Risk in Young Adults study[J]. J Hum Genet,2018,63(3):327-337.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(11):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(11):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(11):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(11):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(11):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]